Your DNA and your First Amendment

The FDA is blocking 23andMe’s genome service. But the real target is free speech.
 

By David Rivkin Jr. and Andrew Grossman 

Did you know that you cannot be trusted with knowledge of your own genetic background? That’s what the Food and Drug Administration decreed late last month when it ordered 23andMe to stop marketing its Personal Genome Service.

23andMe is at the cutting edge of mass-market genomics. For $99 the company tests a saliva sample to identify genetic markers that correspond to various conditions and predispositions, as well as ancestry. Based on these markers, the company produces a report describing genetic health risks and inherited traits, along with citations to the research that backs up its analysis and the current scientific “confidence” for each point.

The FDA does not claim that 23andMe is a scam or could cause direct injury. Instead, its concern is that people using the genome service may begin to self-manage their treatments. Essentially, the agency wants to “protect” patients from knowing about their own health.
Read more »

David Rivkin on the Constitutional Controversy of the IRS Scandal

Constitutional attorney David Rivkin spoke with Bill Bennett during his show “Morning in America” about the recent hearings for the IRS scandal. Rivkin presents the constitutional controversy, as well as speaks about the Lois Lerner hearing, the recusal, and the Holder Administration. Rivkin also presents how the treatment by the IRS is hindering First Amendment rights and predicts how the scandal will progress in the future.